chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received J&J dose 3/13/21, 3 doses of Moderna at our facility on 4/9/21, 5/8/21 or 6/14/21 and two doses of Pfizer 8/24/21 and 9/15/21. No reported adverse events.
I received my first dose in late December 26, 2020, first 6 hours developed tachycardia and palpitations, chest tightness. On 12-30-2021 in the evening sudden onset of pain to my upper chest, back and neck. I went to the ER 12-30-2021 and 12-31-2021.   5 days after I had an episode of pericarditis, the way was manifested was musculoskeletal injury, upper part of my chest. My PCP about one month later, said it was an acute pericarditis. Since that time I have off and on, related to inflammation, pericarditis.  At the ER lab work and D-dimmer was also performed. They did not do a x-ray of the chest.  I can say I do feel overall a little bit more sensitivity in my cardiac stamina.   For my second vaccine, I had bad fever, felt terrible for 24 hours and seemed to go back to baseline pericarditis, tired and achy. I have not had any recurrence after my first vaccine like going to the ER.
pt recv first dose for prophylaxis; exp nausea, fatigue; recovered; pt recv second dose; exp nausea, heart palpitations; recovered w/in one day.
Information has been received from a health professional concerning a 6 year old male who on 30Jul1998 was vaccinated with a dose of varicella virus vaccine live. It was reporter that the school the pt attends had a chickenpox breakout. On approximately 13Nov03 and had approximately 25 to 50 lesions with some pustules already scabbed over. Treatment with cephalexin (KEFLEX) for any secondary infection was given. As of 19Nov03 the pt was recovering. There was no product quality complaint involved.  The reporter indicated that the pt's brother's and two other pt's had similar experiences following exposure to varicella virus vaccine live. Additional information has been requested.
Patient experienced dizziness causing him to fall down twice. Patient appeared physically ok, no harm from falls. Only other symptom was muscle aches.
Patient received Typhoid, Smallpox and Anthrax on 6 DEC 2005. Hospitalized on 14 DEC 05 for fever 104.3F/ treated with Cefuroxim and released without limitations on 20 DEC 05.
11DEC91 began fever approx 6PM inc to 103.0 R p/immun then later that noc inc to 104.6 R; APAP given fever then dec 103.0 R; mom also bathed pt w/cool H20 x 2; 12DEC91 temp 101.0 R; 12DEC91 temp back up to 103 R; pt came to clinic;
Information has been received on 05-JAN-2018 regarding a case in litigation from a lawyer and a male patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. The patient was inoculated with ZOSTAVAX (lot number and expiration unknown) subcutaneous on or about 18-NOV-2016, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of severe herpes zoster. On or about 16-DEC-2016, the patient was treated for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as HSV Keratouveitos OS, herpes zoster or shingles with ocular interference. The patient has been prescribed acyclovir for management of his painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, HSV Keratouveitos OS/herpes zoster or shingles with ocular interference was considered to be medically significant. Additional information has been requested.
Running nose, cough, congestion, light headache, eye pain body aches and pains, light headed.
After receiving HPV injection he became lightheaded and became unconscious for 25-30 seconds and sat on floor. Color pink, skin warm and dry. When became alert again , he stood up and was seated in a chair. Given a snack of juice and gummies.  Denied any further feelings of light-headedness and received remainder of vaccine's with no other  adverse symptoms. Observed for another 15 - 20 minutes. Ambulated from clinic with no assistance. Gait steady.
This spontaneous report as received from a medical assistant refers to a unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with PEDVAXHIB. Dose, route, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. The medical assistant reported that doses of PEDVAXHIB were improperly stored and were administered (on an unknown date). NO adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
This spontaneous report was received from a pharmacy technician and refers to a patient of an unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 23-JUL-2016, the unspecified patient was vaccinated intramuscularly with 0.5 ml dose of improperly stored ZOSTAVAX (lot# and expiration date were not reported). No adverse effect was reported. No further information provided. Additional information has been requested.
The patient called the health department this afternoon stating that 3 days ago she began noticing "light headed, dizziness". I encouraged an ER visit / assessment with MD.
Initial literature report received on 03 Jan 2011: The authors presented 3 cases of lichen planus (LP) occurring after INFLUENZA vaccination. This patient was vaccinated with INFLUENZA (manufacturer and batch number: unknown) and 2 weeks after vaccination the patient developed itchy, erythematous papules on the left leg. The lesions gradually increased in number and size, following the lines of Blaschko or a dermatomal distribution. No oral lesions were observed. Neither hepatitis B virus (HBV) nor HCV infection was detected. A skin biopsy showed a lichenoid tissue reaction consistent with LP. According to the histological and clinical findings, the patient was diagnosed with linear LP. The patient was treated with clobetasol propionate topically. After 6 months, the eruption was completely suppressed. The author commented that subclinical reactivations of varicella zoster virus (though the patient was asymptomatic, the serological evidence does not necessarily exclude the possibility of previous herpes zoster) subsequent to INFLUENZA vaccination may be involved in the occurrence of LP in a striking linear pattern.
client's fiance alerted EMTs client was lightheaded and with nausea. EMT brought client anti-gravity chair and emesis bag. EMT began vitals. PHN  arrived at 1825, client sitting upright in chair, pale, alert and oriented 4. Per client has history of syncope with needles but did not tell vaccinator. Client stated on his way to observation began feeling lightheaded and "felt his heart racing". Vitals at 1925: blood pressure 132/76, pulse 57, oxygen sat 99%. Client stated no additional medical history, no current medication, no known allergies. Client denied headache, blurry vision, nausea, chest pain, palpitations, or shortness of breath. PHN  gave client water and asked client to take small sips. Client asked to stay longer in observation. EMTs stayed with client. Vitals at 1835: blood pressure 135/70, pulse 67, oxygen sat 98%. Client stated nausea resolved and lightheadedness improving. EMT gave client Capri-Sun juice at client's request. Client brought to a sitting position in anti-gravity chair. Client's skin color normal for ethnicity. PHN advised client to not drive, per client fiance would drive. Vitals at 1845: blood pressure 130/68, pulse 60, oxygen 99%. Client stated "there is no more nausea  and no dizziness". Client informed EMTs he wanted to stand up and walk. At 1847 client stated he wanted to leave. EMTs advised client to follow up with provider and gave ER precautions. Client left before completing observation time and left facility with steady gait at 1848.
Experienced debilitating headache for days in addition to nausea and just a very bad feeling after Pfizer 1st shot Due to the terrible feeling and side effects of the 1st shot, I do not wish to get the 2nd shot because it may be worse than my first experience.
Information has been received from a pharmacist concerning a 66 year old female patient with penicillin allergy who on 08-SEP-2009 was vaccinated IM with a 0.5 ml dose of PNEUMOVAX 23(Lot#663888/0627Y). Subsequently the patient said she "felt the vaccine going into her arm". On 09-SEP-2009 the patient woke up in the morning with a lump at the injection site. The patient sought medical attention at the pharmacy. The pharmacist told her to apply ice at the injection site. There were no laboratory studies performed. At the time of the report the patient had not recovered. The pharmacist also reported that the patient had received PNEUMOVAX 23 in the past, but the pharmacist did not know the date. Additional information has been requested.
S: leg tingling B: Noticed RIGHT leg starting in the foot and up her leg noticed a numb or tingly sensation. Describes this as mild, not interfering with activity. Received her 2nd moderna vaccine at a drive thru site around 1230 and sensation started about 1300 and has been persistent (not getting worse or better) A: Pt returned to vaccination site and nurse did a quick assessment, then referred her to call us. Right side of her face felt like when novocain is wearing off - this has resolved. No dizziness or weakness. No other neuro red flags (no HA, vision changes, confusion, speech issues unilateral weakness) able to ambulate. Feels a little shaky.  The leg feels similar to a time she had a reaction to an iron infusion about 4 years ago. Denies any anaphylactic type symptoms
Pt felt very anxious, states initial dizziness that resolved in 30 minutes.  Onset was 15 minutes after vaccination. PT monitored, VS at released from observation area were normal for this patient.
chills with fever of 101. Now down to 100.7,   bad heart burn. Woke up early due to coughing due to Heart Burn.
This is a spontaneous report from a contactable pharmacist based on information received by Pfizer from Merck & Co., Inc, manufacturer control number 00670303. A patient of unspecified age, ethnicity, and gender received PREVNAR 13 (Pfizer; Lot Number: N05077; Expiration Date: 01Sep2017), via an unspecified route of administration on 12Oct2016 at a single dose for immunisation and polysorbate 20 (POLYSORBATE), via an unspecified route of administration on 12Oct2016 at a single dose as an adjuvant. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient who was allergic to polysorbate was administered the vaccine. No adverse effect was reported. The action taken in response to the event for the vaccine and polysorbate 20 was not applicable. The clinical outcome for the event was unknown. No follow up attempts are possible. No further information is expected.
Per patient after 1 day got fever and spreading rash.  Had MD visit via on-line,  and MD had patient start Claritin.
Within 20 min of administration, the patient developed lip numbness with left sided facial paralysis extending into neck. Resolved on its own within 1 hour.
Site: Pain at Injection Site-Severe, Additional Details: Patient is experiencing pain in back as well as injection site. Patient asked location of site. Patient pointed to area on left arm (4 fingers from shoulder within guidelines)
Swollen tongue, sore on tongue. Flu symptoms - nausea, diarrhea, body aches, temp 98.6. Flu symptoms lasted for 1 week. Swollen tongue and sores lasted for 2 days.
Pain increase to her upper abdomen; Spleen slightly enlarge; Liver was slightly enlarge; Excruciating back pain; Severe inflammatory reaction; Back pain felt like drop from a two-story house into a pavement; This spontaneous case was reported by a consumer and describes the occurrence of SPLENOMEGALY (Spleen slightly enlarge), HEPATOMEGALY (Liver was slightly enlarge), BACK PAIN (Excruciating back pain) and ABDOMINAL PAIN UPPER (Pain increase to her upper abdomen) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concurrent medical conditions included Analgesic effect (Patient has been taking PARACETAMOL and IBUPROFEN.).   On 08-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2021, the patient experienced BACK PAIN (Excruciating back pain) (seriousness criterion hospitalization). On 14-Jul-2021, the patient experienced SPLENOMEGALY (Spleen slightly enlarge) (seriousness criterion hospitalization) and HEPATOMEGALY (Liver was slightly enlarge) (seriousness criterion hospitalization). On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Pain increase to her upper abdomen) (seriousness criterion hospitalization), INFLAMMATION (Severe inflammatory reaction) and BACK PAIN (Back pain felt like drop from a two-story house into a pavement). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, SPLENOMEGALY (Spleen slightly enlarge), HEPATOMEGALY (Liver was slightly enlarge), BACK PAIN (Excruciating back pain), ABDOMINAL PAIN UPPER (Pain increase to her upper abdomen), INFLAMMATION (Severe inflammatory reaction) and BACK PAIN (Back pain felt like drop from a two-story house into a pavement) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was hospitalized for 3 days.  Onan unknown date, CT scan showed that spleen and liver was slightly enlarge.  Her inflammatory marker was 72.9, the normal range below 9.  Concomitant products was not provided. The patient was taking other medication (unspecified).  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the medical history/ occurrence of PARACETAMOL and IBUPROFEN could be a contributory factor.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the medical history/ occurrence of PARACETAMOL and IBUPROFEN could be a contributory factor.
Headache, Myalgia, Fever, Localized pain; fatigue Narrative:
Systemic: Dizziness / Lightheadness-Medium, Systemic: Vomiting-Mild, Additional Details: Patient remained in pharmacy until blood pressure was normal and felt better for about 1 hour
Redness, swollen. Left arm 7 1/2 x 6; right arm 1 1/2 x 1.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 76-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Feb2021 at 12:00 as dose 1, single (Lot number: EL9264), in left arm, on 23Feb2021 at 13:15 as dose 2, single (Lot number: EN6198), in left arm and on 24Aug2021 at 14:30 as dose 3 (booster), single (Lot number: EW0180) at the age of 75 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (COVID-19 VACCINE MODERNA), on 29Mar2022 at 14:30 as dose 4 (booster), single (Lot number: 027L21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Sjögren's syndrome" (unspecified if ongoing), notes: controlled; "Known allergies:Sulfa" (unspecified if ongoing). Concomitant medication(s) included: CRESTOR, stop date: 05Aug2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Aug2022) Positive, notes: Covid positive 07Aug2022; (13Aug2022) Negative, notes: Covid negative on 13Aug; (15Aug2022) Positive, notes: Covid positive, 15Aug; (20Aug2022) Positive, notes: Symptoms: fever, myalgia, arthralgia, headache, runny nose, malaise, loss of taste and smell until 20Aug - still Covid positive on test); (21Aug2022) Negative, notes: 21Aug tested negative. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient took Anti-viral medications as COVID 19 Treatment from 07Aug2022 to 11Aug2022. The symptoms included fever, myalgia, arthralgia, headache, runny nose, malaise, loss of taste and smell until 20Aug2022. There were mild symptoms remained to date (25Aug2022). No treatments taken for these symptoms.
devel aching in both hip on 3MAy93 rt more than lt; began taking Ibuporfen; examined on 10MAY93 & Ibporfen charged to Relafen;
Fine erythematous body rash - severe itching chest/back/legs, arms, buttocks, feet, hands/palms, soles over  x 6 days.
Pt received routine WCC IZ's (L) upper arm edema hematoma secondary to hep B vaccine admin on 1/10/13.
Severe joint pain to knees and hands lasting now into 3-4 weeks. Knee pain now gone, hand/joint pain remains. I think the hand/joint pain may be getting better?
Patient had initially registered for flu vaccine at the Public Health clinic and an annual flu vaccine was administered correctly IM inthe Left arm of patient.  During the flu vaccination,  patient reported receiving primary series of COVID vaccine "awhile back" and was wanting to get a COVID booster that day as well.  Patient couldn't remember when primary series was given.  RN did contact PCP to ask for an order for COVID booster vaccine to be administered to patient.  RN receive verbal order from PCP to administer COVID booster vaccine, so Moderna Bivalent COVID booster vaccine was administered that same day to patient.  After clinic was closed and vaccine record entered into register, found that patient had only received ONE primary dose of COVID vaccine on 12/25/2021 (Pfizer-Comirnaty).  Patient informed and she recalled only remembering receiving one dose of COVID vaccine. No adverse events noted or reported from patient after receiving vaccine.
this is 1 of 6 pt from this site to devel flu-like sx & diarrhea 10-14 days p/vax;
Death 4/30/2021 Causes of death listed on death certificate: 1) Acute hypoxemic respiratory failure due to COVID-19 pneumonia  2) COVID-19 pneumonia  3) Acute on chronic left ventricular systolic congestive heart failure  4) Septic shock, liver shock due to COVID-19  Other: Exacerbation of chronic obstructive pulmonary disease, chronic blood loss anemia, diabetes mellitus type II
Started with mild headache that got progressively worse. As the headache worsened body temperature and heart rate rose. Body temp spiked at 103° and resting heartrate rose to 98bpm. Headache began to relieve within 12hrs of onset and heartrate is lower but still elevated.
Minor Swelling / heat at injection site. Headache / tiredness  (common for me for last few years with Flu shot)  Took Tylenol & used cool compress as suggested by pharmacist when I received the vaccination
she had a slight headache that turned into a bad headache; threw up/ vomited; Nausea; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 49-year-old female patient received one dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER5730) via unspecified route on right upper arm single dose for COVID-19 immunization on 30Dec2020 before 10:30AM, at 49-year-old. Medical history and concomitant medication were not reported. On 30Dec2020, 20 minutes after getting the vaccine, the patient had a slight headache that turned into a bad headache by 11AM. Then she went to lunch at 11:30, and after she ate something, she took ibuprofen, then got back from lunch, worked an hour, and threw up. She vomited between 1 and 1:30PM, and vomited a few times and was done, but could still feel a little nausea, but was not going to go throw up. She checked her temperature but didn't have one. Action taken for BNT162B2 was not appliable. Outcome of the event headache was resolving, outcome of the event threw up/ vomited was resolved on 30Dec2020, outcome of the other event was unknown. It was reported as non-serious.
A physician reported that a 16 month old male received Prevnar and ActHIB (Aventis Pasteur SA) vaccines on 7/14/00; both vaccines were injected into the upper left leg. The next morning, the child developed an injection site reaction characterized by an area of redness, swelling, and warmth measuring 5" to 6" by 2" to 3". He was also irritable, restless and sleepy. The mother reported that the child was teething. The physician instructed her to administer acetaminophen and apply warm compresses to the injection site.
Moderna covid-19 vaccine eua 2:45 noticed nausea and heartburn, 7:45 "foggy" and headache, took 2 extra strength tylenol.  Woke at 1 AM with muscle pain and headache.  Took 2 extra strength tylenol at 2 AM.  8AM to 7:00PM had confusion and extreme chills, plus continued fatigue, muscle ache, and nausea combined.  Took Ibuprofen at 8 AM and 2 PM.  At 7:30 PM all symptoms subsided within 30 min.
covid vaccine administered to unauthorized age group- age 11 instead of 12. Unable to reach patient or parents at phone number provided. Patient's form was filled with incorrect date of birth, indicating that she was 12. Patient also verbally confirmed she was 12 years old. Outside medical records indicate otherwise.
Second day after vaccine around noon she felt dizzy; she was laying down and her heart felt like it was beating really hard; was like leaning to the left; First day I had fatigue; This is a spontaneous report from a contactable consumer. A 36-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0185, Expiry date: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 18May2021 09:15 as dose 1, single for covid-19 immunisation administered at Pharmacy or Drug Store. Medical history included Penicillin allergy. Concomitant medications within 2 weeks of vaccination includes womens multivitamin. The patient did not receive any treatment for the event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18May2021 18:00, the patient reported, first day she had fatigue, she was laying down and her heart felt like it was beating really hard. Second day after vaccine around noon she felt dizzy and was like leaning to the left. It went away that night. She need to know whether to get the second dose. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. Outcome of events was recovered on an unspecified date in May2021.   Follow-up attempts are completed. No further information is expected.
Extremely mild: headache, site injection soreness.   Mild: difficulty breathing - required oxygen & sleepiness. Also, antagonized my dry eye problem - requiring drops every couple of hours round the clock instead of just twice a day.
Very sore left arm, extremely itchy, red and lumpy spots under skin. Had low fever 100deg. Started same nite as shot. Still sore, itchy, red, with large lumps under skin at injection site. Fever gone.